The price of Mili, an investigational drug developed by Astellas Pharma for menopausal hot flashes, has not yet been publicly disclosed. As the drug is still undergoing regulatory review, specific pricing details are typically not released until closer to potential market approval.
How is Mili expected to be priced?
The pricing of Mili will likely be influenced by several factors, including its clinical efficacy, the prevalence of its target condition (menopausal hot flashes), and the pricing of existing treatments. Prescription drug prices in the United States are often set by pharmaceutical manufacturers and can vary significantly based on these considerations, as well as market demand and insurance reimbursement.
What is Mili and how does it work?
Mili, also known by its investigational name fezolinetant, is a non-hormonal oral medication. It works by targeting the neurokinin 3 (NK3) receptor in the brain, which is believed to play a role in regulating body temperature. By blocking this receptor, Mili aims to reduce the frequency and severity of hot flashes and night sweats associated with menopause.
When might Mili become available?
Astellas Pharma submitted a New Drug Application (NDA) for fezolinetant to the U.S. Food and Drug Administration (FDA) in September 2022. The FDA has set a target action date of February 2023 for this application. If approved, Mili could become available to patients shortly thereafter.
What other treatments are available for hot flashes?
Current treatment options for menopausal hot flashes include hormone therapy (HT) and non-hormonal prescription medications such as Brisdelle (paroxetine mesylate) and certain antidepressants. Over-the-counter remedies and lifestyle modifications are also utilized by some individuals. Mili offers a potential new non-hormonal option.
What are the potential side effects of Mili?
The most common side effects observed in clinical trials for fezolinetant included abdominal pain, diarrhea, insomnia, and back pain. The FDA's review will assess the overall safety profile of the drug.
Are there any patents related to Mili?
Information regarding specific patents covering fezolinetant is available through specialized databases. DrugPatentWatch.com provides extensive patent information on pharmaceutical products.